Specialty drugs: background and policy concerns -- Prescription drug discount couons: implications for public and commercial health care plans -- Manufacturer safeguards may not prevent copayment coupon use for part D drugs -- Pharmaceutical patent-antitrust: reverse payment settlements and product hopping.
Local Note
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America